Allarity Therapeutics Expands its Stenoparib License Rights to Include Anti-Viral Uses Press Release       Hørsholm, Denmark (14 December 2020) – Allarity Therapeutics A/S (“Allarity” or the “Company”) today announced that it has amended its license agreement with Eisai Co., Ltd....